Protein kinase C beta overexpression induces fibrotic effects in human proximal tubular epithelial cells

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 10, 2008, Pages 2218-2229

  Slattery, Craig ^a   Ryan, Michael P ^b   McMorrow, Tara ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Fibronectin; Protein kinase C beta; Transforming growth factor beta

Indexed keywords

CYCLOSPORIN A; CYTOKINE; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA I; PROTEIN KINASE C BETA II; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

BUTADIENES; CELL LINE; CELL SHAPE; CYCLOSPORINE; ENZYME ACTIVATION; EPITHELIAL CELLS; FIBRONECTINS; FIBROSIS; GREEN FLUORESCENT PROTEINS; HUMANS; IMIDAZOLES; ISOENZYMES; KIDNEY TUBULES, PROXIMAL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PHENOTYPE; PROTEIN KINASE C; PYRIDINES; PYRONES; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 48949116154     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.03.005     Document Type: Article

References (43)

1. Baricos W.H. Chronic renal disease: do metalloproteinase inhibitors have a demonstrable role in extracellular matrix accumulation?. Chronic Curr Opin Nephrol Hypertens 4 4 (1995) 365-368
2. Becker K.P., and Hannun Y.A. Isoenzyme-specific translocation of protein kinase C (PKC)betaII and not PKCbetaI to a juxtanuclear subset of recycling endosomes: involvement of phospholipase D. J Biol Chem 279 27 (2004) 28251-28256
3. Bennett W.M., DeMattos A., Meyer M.M., Andoh T., and Barry J.M. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 50 4 (1996) 1089-1100
4. Border W.A., Brees D., and Noble N.A. Transforming growth factor-beta and extracellular matrix deposition in the kidney. Chronic Contrib Nephrol 107 (1994) 140-145
5. Border W.A., and Noble N.A. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 51 5 (1997) 1388-1396
6. Bottinger E.P., and Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 13 10 (2002) 2600-2610
7. Feng X., Zhang J., Barak L.S., Meyer T., Caron M.G., and Hannun Y.A. Visualization of dynamic trafficking of a protein kinase C betaII/green fluorescent protein conjugate reveals differences in G protein-coupled receptor activation and desensitization. J Biol Chem 273 17 (1998) 10755-10762
8. Ha H., and Lee H.B. Reactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol 14 8 Suppl. 3 (2003) S246-S249
9. Haneda M., Koya D., and Kikkawa R. Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway. Am J Kidney Dis 38 4 Suppl. 1 (2001) S178-S181
10. Hewitson T.D., Wu H.L., and Becker G.J. Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 15 5 (1995) 411-417
11. Johnson D.W., Saunders H.J., Johnson F.J., Huq S.O., Field M.J., and Pollock C.A. Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor. J Pharmacol Exp Ther 289 1 (1999) 535-542
12. Keane T., Egan D., and Ryan M.P. Signalling pathways involved in cyclosporine A-induced TGF-β1 secretion from a renal tubular epithelial cell line. J Am Soc Nephrol 9 (1998) A3045
13. Kiely B., Feldman G., and Ryan M.P. Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance. Kidney Int 63 3 (2003) 908-916
14. Koya D., and King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes 47 6 (1998) 859-866
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 259 (1970) 680-685
16. Lan H.Y. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 12 1 (2003) 25-29
17. McMorrow T., Gaffney M.M., Slattery C., Campbell E., and Ryan M.P. Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol Dial Transplant 20 10 (2005) 2215-2225
18. Meier M., Menne J., Park J.K., and Haller H. Nailing down PKC isoform specificity in diabetic nephropathy two's company, three's a crowd. Nephrol Dial Transplant 22 9 (2007) 2421-2425
19. Meier M., Park J.K., Overheu D., Kirsch T., Lindschau C., Gueler F., Leitges M., Menne J., and Haller H. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model. Diabetes 56 2 (2007) 346-354
20. Miettinen P.J., Ebner R., Lopez A.R., and Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127 6 Pt 2 (1994) 2021-2036
21. Murphy M., McGinty A., and Godson C. Protein kinases C: potential targets for intervention in diabetic nephropathy. Curr Opin Nephrol Hypertens 7 5 (1998) 563-570
22. Nakamura T., Miller D., Ruoslahti E., and Border W.A. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int 41 5 (1992) 1213-1221
23. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9 7 (1995) 484-496
24. Obeid L.M., Okazaki T., Karolak L.A., and Hannun Y.A. Transcriptional regulation of protein kinase C by 1,25-dihydroxyvitamin D3 in HL-60 cells. J Biol Chem 265 4 (1990) 2370-2374
25. Ohshiro Y., Ma R.C., Yasuda Y., Hiraoka-Yamamoto J., Clermont A.C., Isshiki K., Yagi K., Arikawa E., Kern T.S., and King G.L. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 55 11 (2006) 3112-3120
26. Oriji G.K., and Keiser H.R. Nitric oxide in cyclosporine A-induced hypertension: role of protein kinase C. Am J Hypertens 12 11 Pt 1 (1999) 1091-1097
27. Parra T., de Arriba G., Conejo J.R., Cantero M., Arribas I., Rodriguez-Puyol D., Rodriguez-Puyol M., and Carballo F. Cyclosporine increases local glomerular synthesis of reactive oxygen species in rats: effect of vitamin E on cyclosporine nephrotoxicity. Transplantation 66 10 (1998) 1325-1329
28. Paslaru L., Trigon S., Kuhlmann M., and Morange M. MAP kinase activation by cyclosporine A. Biochem Biophys Res Commun 236 3 (1997) 599-603
29. Pfaller W., Gstraunthaler G., and Willinger C.C. Morphology of renal tubular damage from nephrotoxins. Toxicol Lett 53 1-2 (1990) 39-43
30. Piek E., Heldin C.H., and Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 13 15 (1999) 2105-2124
31. Remuzzi G., Ruggenenti P., and Benigni A. Understanding the nature of renal disease progression. Kidney Int 51 1 (1997) 2-15
32. Rodriguez-Pena A., Eleno N., Duwell A., Arevalo M., Perez-Barriocanal F., Flores O., Docherty N., Bernabeu C., Letarte M., and Lopez-Novoa J.M. Endoglin upregulation during experimental renal interstitial fibrosis in mice. Hypertension 40 5 (2002) 713-720
33. Ryan M.J., Johnson G., Kirk J., Fuerstenberg S.M., Zager R.A., and Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45 1 (1994) 48-57
34. Slattery C., Campbell E., McMorrow T., and Ryan M.P. Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. Am J Pathol 167 2 (2005) 395-407
35. Strutz F., and Muller G.A. Transdifferentiation comes of age. Nephrol Dial Transplant 15 11 (2000) 1729-1731
36. Strutz F., Zeisberg M., Ziyadeh F.N., Yang C.Q., Kalluri R., Muller G.A., and Neilson E.G. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61 5 (2002) 1714-1728
37. Tomooka S., Border W.A., Marshall B.C., and Noble N.A. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 42 6 (1992) 1462-1469
38. Toyoda M., Suzuki D., Honma M., Uehara G., Sakai T., Umezono T., and Sakai H. High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy. Kidney Int 66 3 (2004) 1107-1114
39. Tuttle K.R., and Anderson P.W. A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition. Am J Kidney Dis 42 3 (2003) 456-465
40. Tuttle K.R., Johnson E.C., Cooney S.K., Anderberg R.J., Johnson E.K., Clifton G.D., and Meek R.L. Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C. Kidney Int 67 3 (2005) 953-968
41. Williams M.E., and Tuttle K.R. The next generation of diabetic nephropathy therapies: an update. Adv Chronic Kidney Dis 12 2 (2005) 212-222
42. Yang J., and Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159 4 (2001) 1465-1475
43. Zavadil J., Bitzer M., Liang D., Yang Y.C., Massimi A., Kneitz S., Piek E., and Bottinger E.P. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A 98 12 (2001) 6686-6691